Adma Biologics Inc (ADMA) returns
Adma Biologics returns over 10 years
$1,000 invested in Adma Biologics ten years ago was worth $1,944 at the close on October 30, 2026, with dividends reinvested: an average return of 6.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +13.8% | — | $1,138 | -0.9% |
| 3 months | +31.6% | — | $1,316 | +2.1% |
| Year to date | -37.4% | — | $625.55 | +11.7% |
| 1 year | -25.3% | — | $747.22 | +12.4% |
| 3 years | +245.8% | +51.2% | $3,458 | +88.5% |
| 5 years | +784.5% | +54.6% | $8,845 | +76.0% |
| 10 years | +94.4% | +6.9% | $1,944 | +316.6% |
Adma Biologics return by calendar year
| Year | ADMA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -37.4% | +11.7% | -49.1% |
| 2025 | +6.4% | +17.7% | -11.4% |
| 2024 | +279.4% | +24.9% | +254.5% |
| 2023 | +16.5% | +26.2% | -9.7% |
| 2022 | +175.2% | -18.2% | +193.3% |
| 2021 | -27.7% | +28.7% | -56.4% |
| 2020 | -51.2% | +18.4% | -69.6% |
| 2019 | +67.4% | +31.2% | +36.1% |
| 2018 | -25.5% | -4.6% | -21.0% |
| 2017 | -37.3% | +21.7% | -59.0% |
| 2016 | -36.6% | +12.0% | -48.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ADMA financials · ADMA valuation
No forecast, no recommendation. This page describes Adma Biologics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.